These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 7507230)

  • 81. Quantitative and qualitative variation of ETS-1 transcripts in hematologic malignancies.
    Collyn d'Hooghe M; Galiègue-Zouitina S; Szymiczek D; Lantoine D; Quief S; Loucheux-Lefebvre MH; Kerckaert JP
    Leukemia; 1993 Nov; 7(11):1777-85. PubMed ID: 8231246
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cloning and expression of chicken p54c-ets cDNAs: the first p54c-ets coding exon is located into the 40.0 kbp genomic domain unrelated to v-ets.
    Duterque-Coquillaud M; Leprince D; Flourens A; Henry C; Ghysdael J; Debuire B; Stehelin D
    Oncogene Res; 1988 May; 2(4):335-44. PubMed ID: 3041344
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Basal transcription of the mouse sarco(endo)plasmic reticulum Ca2+-ATPase type 3 gene in endothelial cells is controlled by Ets-1 and Sp1.
    Hadri L; Ozog A; Soncin F; Lompré AM
    J Biol Chem; 2002 Sep; 277(39):36471-8. PubMed ID: 12119294
    [TBL] [Abstract][Full Text] [Related]  

  • 84. ETS transcription factors regulate an enhancer activity in the third intron of TNF-alpha.
    Tomaras GD; Foster DA; Burrer CM; Taffet SM
    J Leukoc Biol; 1999 Jul; 66(1):183-93. PubMed ID: 10411007
    [TBL] [Abstract][Full Text] [Related]  

  • 85. cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1.
    Thompson CB; Wang CY; Ho IC; Bohjanen PR; Petryniak B; June CH; Miesfeldt S; Zhang L; Nabel GJ; Karpinski B
    Mol Cell Biol; 1992 Mar; 12(3):1043-53. PubMed ID: 1545787
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer-associated gene expression.
    Eckel KL; Tentler JJ; Cappetta GJ; Diamond SE; Gutierrez-Hartmann A
    DNA Cell Biol; 2003 Feb; 22(2):79-94. PubMed ID: 12713734
    [TBL] [Abstract][Full Text] [Related]  

  • 87. An intricate arrangement of binding sites for the Ets family of transcription factors regulates activity of the alpha 4 integrin gene promoter.
    Rosen GD; Barks JL; Iademarco MF; Fisher RJ; Dean DC
    J Biol Chem; 1994 Jun; 269(22):15652-60. PubMed ID: 8195215
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Dual regulation of ets-activated gene expression by SP1.
    Kelley KM; Wang H; Ratnam M
    Gene; 2003 Mar; 307():87-97. PubMed ID: 12706891
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation.
    Koizumi S; Fisher RJ; Fujiwara S; Jorcyk C; Bhat NK; Seth A; Papas TS
    Oncogene; 1990 May; 5(5):675-81. PubMed ID: 2189104
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1.
    Mertz JA; Mustafa F; Meyers S; Dudley JP
    J Virol; 2001 Mar; 75(5):2174-84. PubMed ID: 11160721
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A phorbol ester response element within the human T-cell receptor beta-chain enhancer.
    Prosser HM; Wotton D; Gegonne A; Ghysdael J; Wang S; Speck NA; Owen MJ
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9934-8. PubMed ID: 1409722
    [TBL] [Abstract][Full Text] [Related]  

  • 92. GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression.
    Lemarchandel V; Ghysdael J; Mignotte V; Rahuel C; Roméo PH
    Mol Cell Biol; 1993 Jan; 13(1):668-76. PubMed ID: 8417360
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Characterization of the murine C3a receptor enhancer-promoter: expression control by an activator protein 1 sequence and an Ets-like site.
    Martin CB; Martin BK
    J Immunol; 2005 Sep; 175(5):3123-32. PubMed ID: 16116202
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A factor discriminating between the wild-type and a mutant polyomavirus enhancer.
    Kovesdi I; Satake M; Furukawa K; Reichel R; Ito Y; Nevins JR
    Nature; 1987 Jul 2-8; 328(6125):87-9. PubMed ID: 3037380
    [TBL] [Abstract][Full Text] [Related]  

  • 95. ETS1 suppresses tumorigenicity of human colon cancer cells.
    Suzuki H; Romano-Spica V; Papas TS; Bhat NK
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4442-6. PubMed ID: 7753825
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A single amino-acid substitution in the Ets domain alters core DNA binding specificity of Ets1 to that of the related transcription factors Elf1 and E74.
    Bosselut R; Levin J; Adjadj E; Ghysdael J
    Nucleic Acids Res; 1993 Nov; 21(22):5184-91. PubMed ID: 8255775
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Fli1, Elf1, and Ets1 regulate the proximal promoter of the LMO2 gene in endothelial cells.
    Landry JR; Kinston S; Knezevic K; Donaldson IJ; Green AR; Göttgens B
    Blood; 2005 Oct; 106(8):2680-7. PubMed ID: 15994290
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins.
    Sun W; Graves BJ; Speck NA
    J Virol; 1995 Aug; 69(8):4941-9. PubMed ID: 7609063
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Trans-activation of the mouse cytomegalovirus immediate early gene enhancer by ras oncogenes.
    Lembo D; Angeretti A; Foresta P; Gribaudo G; Gariglio M; Landolfo S
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1685-92. PubMed ID: 8021597
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.
    Xu D; Wilson TJ; Chan D; De Luca E; Zhou J; Hertzog PJ; Kola I
    EMBO J; 2002 Aug; 21(15):4081-93. PubMed ID: 12145208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.